| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.698 | 0.024 | 0.771 | Caspase 9 stimulant | 0.693 0.025 CID_154699726 0.771 0.015 CID_15629705 | CID_15629705 | |
| 0.667 | 0.004 | 0.667 | GABA C receptor rho-3 antagonist | 0.293 0.121 CID_154699726 0.486 0.03 CID_15629705 | ||
| 0.673 | 0.01 | 0.673 | Aldehyde oxidase inhibitor | 0.184 0.114 CID_154699726 0.386 0.049 CID_15629705 | ||
| 0.628 | 0.008 | 0.628 | 5 Hydroxytryptamine release inhibitor | 0.284 0.184 CID_154699726 0.426 0.063 CID_15629705 | ||
| 0.605 | 0.014 | 0.605 | 5 Hydroxytryptamine release stimulant | 0.184 0.136 CID_154699726 0.363 0.053 CID_15629705 | ||
| 0.535 | 0.007 | 0.535 | Peroxidase inhibitor | 0.265 0.044 CID_15629705 | ||
| 0.538 | 0.019 | 0.538 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.379 0.121 CID_15629705 | ||
| 0.531 | 0.02 | 0.531 | Histamine release inhibitor | 0.263 0.146 CID_154699726 0.383 0.084 CID_15629705 | ||
| 0.522 | 0.02 | 0.522 | Calcium channel L-type activator | 0.253 0.202 CID_15629705 | ||
| 0.495 | 0.005 | 0.495 | Alpha-N-acetylglucosaminidase inhibitor | 0.167 0.046 CID_154699726 0.264 0.021 CID_15629705 | ||
| 0.483 | 0.007 | 0.483 | CDC-like kinase 4 inhibitor | |||
| 0.485 | 0.014 | 0.485 | Superoxide dismutase inhibitor | 0.214 0.103 CID_15629705 | ||
| 0.458 | 0.005 | 0.458 | Tyrosine 3 hydroxylase inhibitor | 0.22 0.103 CID_154699726 0.283 0.043 CID_15629705 | ||
| 0.467 | 0.016 | 0.467 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.45 | 0.007 | 0.45 | 5 Hydroxytryptamine uptake stimulant | 0.275 0.06 CID_154699726 0.323 0.035 CID_15629705 | ||
| 0.448 | 0.01 | 0.448 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.447 | 0.012 | 0.447 | Clk dual-specificity kinase inhibitor | |||
| 0.451 | 0.019 | 0.451 | Dyrk kinase inhibitor | |||
| 0.439 | 0.013 | 0.439 | Calcium channel activator | 0.217 0.188 CID_154699726 0.32 0.073 CID_15629705 | ||
| 0.437 | 0.031 | 0.437 | Aryl hydrocarbon receptor agonist | |||
| 0.406 | 0.005 | 0.406 | GABA C receptor agonist | 0.105 0.062 CID_154699726 0.143 0.037 CID_15629705 | ||
| 0.408 | 0.016 | 0.408 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.396 | 0.009 | 0.396 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.398 | 0.018 | 0.398 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.382 | 0.004 | 0.59 | T cell inhibitor | 0.527 0.003 CID_154699726 0.59 0.003 CID_15629705 | CID_15629705 | |
| 0.387 | 0.017 | 0.387 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.381 | 0.02 | 0.381 | Death-associated protein kinase 3 inhibitor | |||
| 0.355 | 0.005 | 0.355 | Ferrochelatase inhibitor | 0.145 0.04 CID_15629705 | ||
| 0.36 | 0.014 | 0.36 | Protein kinase C nu inhibitor | |||
| 0.366 | 0.022 | 0.366 | Cyclic AMP phosphodiesterase inhibitor | 0.223 0.078 CID_154699726 0.221 0.08 CID_15629705 | ||
| 0.353 | 0.012 | 0.353 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.215 0.061 CID_15629705 | ||
| 0.341 | 0.004 | 0.341 | GABA C receptor rho-2 antagonist | 0.189 0.035 CID_15629705 | ||
| 0.351 | 0.02 | 0.351 | CDC-like kinase 2 inhibitor | |||
| 0.332 | 0.007 | 0.332 | Cystathionine beta-synthase inhibitor | 0.114 0.063 CID_154699726 0.215 0.021 CID_15629705 | ||
| 0.335 | 0.013 | 0.335 | NOS3 expression enhancer | |||
| 0.326 | 0.004 | 0.326 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.129 0.119 CID_15629705 | ||
| 0.343 | 0.025 | 0.343 | RNA-directed DNA polymerase inhibitor | 0.218 0.076 CID_154699726 0.218 0.076 CID_15629705 | ||
| 0.341 | 0.025 | 0.341 | Anesthetic general | 0.147 0.117 CID_154699726 0.146 0.118 CID_15629705 | ||
| 0.334 | 0.02 | 0.334 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.325 | 0.013 | 0.325 | Neurotrophic factor enhancer | 0.219 0.059 CID_154699726 0.238 0.046 CID_15629705 | ||
| 0.33 | 0.023 | 0.33 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.378 | 0.073 | 0.378 | MAP kinase kinase 6 inhibitor | |||
| 0.344 | 0.043 | 0.397 | DNA damaging | 0.397 0.029 CID_154699726 0.313 0.052 CID_15629705 | CID_154699726 | |
| 0.301 | 0.005 | 0.301 | 5 Hydroxytryptamine 3E antagonist | 0.174 0.122 CID_154699726 0.216 0.04 CID_15629705 | ||
| 0.305 | 0.01 | 0.305 | Succinate dehydrogenase inhibitor | 0.161 0.094 CID_154699726 0.215 0.038 CID_15629705 | ||
| 0.312 | 0.018 | 0.312 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.356 | 0.062 | 0.356 | Cholesterol antagonist | 0.271 0.11 CID_15629705 | ||
| 0.331 | 0.044 | 0.331 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.303 | 0.017 | 0.303 | Protein kinase (CK1) gamma inhibitor | |||
| 0.332 | 0.052 | 0.342 | Hypoxia-inducible factor 1 alpha inhibitor | 0.342 0.048 CID_154699726 0.272 0.082 CID_15629705 | CID_154699726 | |
| 0.283 | 0.005 | 0.283 | GABA C receptor antagonist | 0.103 0.073 CID_154699726 0.153 0.028 CID_15629705 | ||
| 0.29 | 0.013 | 0.29 | Aldehyde dehydrogenase inhibitor | 0.118 0.073 CID_15629705 | ||
| 0.281 | 0.004 | 0.281 | CYP2A6 inhibitor | 0.084 0.045 CID_154699726 0.14 0.019 CID_15629705 | ||
| 0.304 | 0.028 | 0.304 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.322 | 0.046 | 0.322 | Insulysin inhibitor | |||
| 0.28 | 0.004 | 0.28 | Phenylalanine 4-hydroxylase inhibitor | 0.106 0.023 CID_15629705 | ||
| 0.347 | 0.075 | 0.347 | Vasodilator, peripheral | |||
| 0.284 | 0.013 | 0.284 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.302 | 0.032 | 0.302 | Gastrin inhibitor | |||
| 0.299 | 0.03 | 0.299 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.276 | 0.012 | 0.276 | UDP-glucose 4-epimerase inhibitor | 0.105 0.056 CID_154699726 0.17 0.023 CID_15629705 | ||
| 0.271 | 0.006 | 0.271 | Porphobilinogen synthase inhibitor | 0.065 0.061 CID_15629705 | ||
| 0.297 | 0.036 | 0.297 | MAP kinase kinase 2 inhibitor | |||
| 0.294 | 0.034 | 0.294 | Growth hormone agonist | |||
| 0.265 | 0.007 | 0.265 | Activin receptor-like kinase 4 inhibitor | |||
| 0.278 | 0.021 | 0.278 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.26 | 0.004 | 0.26 | GABA C receptor rho-1 antagonist | 0.129 0.033 CID_15629705 | ||
| 0.324 | 0.068 | 0.556 | Caspase 3 stimulant | 0.556 0.014 CID_154699726 0.401 0.044 CID_15629705 | CID_154699726 | |
| 0.26 | 0.005 | 0.26 | Photosensitizer | 0.112 0.068 CID_154699726 0.156 0.027 CID_15629705 | ||
| 0.26 | 0.009 | 0.26 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.133 0.032 CID_154699726 0.139 0.03 CID_15629705 | ||
| 0.271 | 0.021 | 0.271 | Nitric-oxide synthase stimulant | 0.21 0.073 CID_15629705 | ||
| 0.265 | 0.015 | 0.265 | Topoisomerase I inhibitor | 0.105 0.066 CID_15629705 | ||
| 0.269 | 0.022 | 0.269 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.252 | 0.005 | 0.252 | HIV-1 integrase (Overall Integration) inhibitor | 0.14 0.029 CID_15629705 | ||
| 0.267 | 0.021 | 0.267 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.249 | 0.005 | 0.249 | Alcohol oxidase inhibitor | 0.065 0.032 CID_15629705 | ||
| 0.254 | 0.011 | 0.254 | Mannose-6-phosphate isomerase inhibitor | 0.142 0.071 CID_15629705 | ||
| 0.245 | 0.005 | 0.245 | MAP3K9 inhibitor | 0.152 0.057 CID_154699726 0.132 0.091 CID_15629705 | ||
| 0.255 | 0.016 | 0.255 | DNA intercalator | |||
| 0.252 | 0.013 | 0.326 | ATPase inhibitor | 0.313 0.005 CID_154699726 0.326 0.005 CID_15629705 | CID_15629705 | |
| 0.291 | 0.053 | 0.291 | Interleukin agonist | |||
| 0.296 | 0.058 | 0.296 | Transcription factor STAT inhibitor | |||
| 0.284 | 0.049 | 0.284 | DNA synthesis inhibitor | 0.221 0.093 CID_154699726 0.212 0.105 CID_15629705 | ||
| 0.239 | 0.008 | 0.239 | Triose-phosphate isomerase inhibitor | 0.117 0.034 CID_15629705 | ||
| 0.236 | 0.007 | 0.236 | 5 Hydroxytryptamine 3A agonist | 0.094 0.083 CID_15629705 | ||
| 0.309 | 0.08 | 0.309 | Vasodilator, coronary | 0.251 0.133 CID_154699726 0.296 0.09 CID_15629705 | ||
| 0.236 | 0.009 | 0.236 | CF transmembrane conductance regulator agonist | 0.147 0.081 CID_15629705 | ||
| 0.233 | 0.007 | 0.233 | Creatine kinase inhibitor | 0.098 0.062 CID_154699726 0.139 0.029 CID_15629705 | ||
| 0.253 | 0.03 | 0.253 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.256 | 0.034 | 0.256 | I kappa B kinase epsilon inhibitor | |||
| 0.24 | 0.019 | 0.24 | Hexokinase inhibitor | |||
| 0.246 | 0.027 | 0.246 | Histone acetyltransferase inhibitor | |||
| 0.328 | 0.113 | 0.328 | 15-Lipoxygenase inhibitor | 0.238 0.175 CID_154699726 | ||
| 0.277 | 0.065 | 0.277 | Transcription factor STAT3 inhibitor | |||
| 0.215 | 0.004 | 0.215 | Glutamate release inhibitor | 0.124 0.019 CID_154699726 0.139 0.013 CID_15629705 | ||
| 0.249 | 0.039 | 0.249 | LIM domain kinase 1 inhibitor | |||
| 0.349 | 0.139 | 0.669 | Apoptosis agonist | 0.669 0.036 CID_154699726 0.655 0.038 CID_15629705 | CID_154699726 | |
| 0.215 | 0.007 | 0.215 | Protein kinase C delta inhibitor | |||
| 0.26 | 0.054 | 0.26 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.218 | 0.013 | 0.218 | Adenylate kinase inhibitor | 0.12 0.043 CID_15629705 | ||
| 0.29 | 0.085 | 0.29 | 12-Lipoxygenase inhibitor | |||
| 0.208 | 0.003 | 0.208 | Purinergic P2Y14 antagonist | |||
| 0.213 | 0.009 | 0.662 | Estrogen receptor beta antagonist | 0.203 0.009 CID_154699726 0.662 0.003 CID_15629705 | CID_15629705 | |
| 0.232 | 0.029 | 0.232 | Phospholipase C inhibitor | 0.149 0.108 CID_15629705 | ||
| 0.272 | 0.072 | 0.272 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.208 | 0.008 | 0.208 | Prolactin inhibitor | 0.137 0.028 CID_154699726 0.114 0.043 CID_15629705 | ||
| 0.21 | 0.011 | 0.21 | MAP kinase kinase 4 inhibitor | |||
| 0.294 | 0.097 | 0.361 | Transcription factor NF kappa B inhibitor | 0.361 0.073 CID_154699726 0.265 0.117 CID_15629705 | CID_154699726 | |
| 0.208 | 0.013 | 0.208 | Telomerase inhibitor | |||
| 0.22 | 0.027 | 0.22 | Neurotensin receptor agonist | 0.139 0.133 CID_15629705 | ||
| 0.213 | 0.022 | 0.213 | Arachidonic acid antagonist | 0.187 0.046 CID_154699726 0.198 0.035 CID_15629705 | ||
| 0.216 | 0.03 | 0.216 | NADPH oxidase inhibitor | |||
| 0.213 | 0.028 | 0.213 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.246 | 0.06 | 0.246 | Neuropeptide Y2 antagonist | |||
| 0.199 | 0.014 | 0.256 | Antineoplastic alkaloid | 0.256 0.004 CID_154699726 0.096 0.05 CID_15629705 | CID_154699726 | |
| 0.199 | 0.014 | 0.199 | Protein kinase C gamma inhibitor | 0.095 0.086 CID_15629705 | ||
| 0.231 | 0.048 | 0.231 | Focal adhesion kinase 2 inhibitor | |||
| 0.188 | 0.005 | 0.188 | Lanosterol 14 alpha demethylase inhibitor | 0.121 0.03 CID_15629705 | ||
| 0.197 | 0.015 | 0.197 | Adenylate cyclase stimulant | 0.135 0.091 CID_154699726 0.157 0.052 CID_15629705 | ||
| 0.193 | 0.011 | 0.193 | NADH dehydrogenase inhibitor | 0.085 0.064 CID_154699726 0.128 0.025 CID_15629705 | ||
| 0.195 | 0.013 | 0.195 | Alcohol dehydrogenase inhibitor | |||
| 0.187 | 0.006 | 0.187 | I kappa B kinase 1 inhibitor | |||
| 0.212 | 0.032 | 0.212 | Activin receptor-like kinase 2 inhibitor | |||
| 0.185 | 0.005 | 0.185 | Ca2+-transporting ATPase inhibitor | 0.153 0.035 CID_154699726 0.168 0.014 CID_15629705 | ||
| 0.218 | 0.039 | 0.218 | Heat shock protein 90 alpha antagonist | 0.188 0.057 CID_154699726 0.197 0.051 CID_15629705 | ||
| 0.192 | 0.014 | 0.587 | Estrogen antagonist | 0.211 0.012 CID_154699726 0.587 0.004 CID_15629705 | CID_15629705 | |
| 0.208 | 0.032 | 0.208 | CDC-like kinase 1 inhibitor | |||
| 0.196 | 0.019 | 0.196 | Carbonic anhydrase XV inhibitor | 0.097 0.071 CID_15629705 | ||
| 0.24 | 0.064 | 0.24 | Pyruvate kinase inhibitor | |||
| 0.226 | 0.05 | 0.226 | Insulin sensitizer | 0.174 0.102 CID_15629705 | ||
| 0.196 | 0.021 | 0.196 | Nav1.6 sodium channel blocker | |||
| 0.228 | 0.053 | 0.228 | Non-steroidal antiinflammatory agent | 0.142 0.127 CID_154699726 | ||
| 0.205 | 0.032 | 0.205 | Topoisomerase II inhibitor | |||
| 0.236 | 0.064 | 0.236 | Psychostimulant | |||
| 0.185 | 0.013 | 0.185 | Phosphodiesterase 7B inhibitor | |||
| 0.189 | 0.017 | 0.189 | Catalase inhibitor | |||
| 0.204 | 0.034 | 0.204 | Toll-Like receptor 9 antagonist | |||
| 0.182 | 0.011 | 0.182 | Heat shock protein 70 antagonist | 0.136 0.093 CID_15629705 | ||
| 0.188 | 0.018 | 0.188 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.196 | 0.026 | 0.196 | Adenylate cyclase inhibitor | |||
| 0.29 | 0.12 | 0.29 | Calpain 2 inhibitor | |||
| 0.18 | 0.01 | 0.18 | DOPA decarboxylase inhibitor | 0.106 0.065 CID_15629705 | ||
| 0.207 | 0.038 | 0.207 | Melanin inhibitor | 0.15 0.082 CID_154699726 0.155 0.075 CID_15629705 | ||
| 0.174 | 0.007 | 0.174 | Acetylcholine release stimulant | 0.1 0.088 CID_15629705 | ||
| 0.183 | 0.017 | 0.183 | Pregnane X receptor agonist | 0.134 0.09 CID_154699726 0.144 0.064 CID_15629705 | ||
| 0.179 | 0.014 | 0.179 | DNA repair enzyme inhibitor | 0.114 0.085 CID_15629705 | ||
| 0.17 | 0.005 | 0.17 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.185 | 0.022 | 0.185 | GABA receptor agonist | |||
| 0.178 | 0.014 | 0.178 | Protein kinase C zeta inhibitor | 0.083 0.079 CID_15629705 | ||
| 0.206 | 0.042 | 0.206 | Amylase inhibitor | |||
| 0.199 | 0.037 | 0.464 | Tubulin antagonist | 0.464 0.009 CID_154699726 0.298 0.019 CID_15629705 | CID_154699726 | |
| 0.186 | 0.027 | 0.186 | Cathepsin H inhibitor | 0.122 0.072 CID_15629705 | ||
| 0.175 | 0.016 | 0.175 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.175 | 0.016 | 0.185 | Sphingomyelinase inhibitor | 0.185 0.013 CID_154699726 0.182 0.014 CID_15629705 | CID_154699726 | |
| 0.188 | 0.03 | 0.188 | Toll-Like receptor 2 antagonist | |||
| 0.183 | 0.025 | 0.183 | MAP kinase 13 inhibitor | |||
| 0.164 | 0.008 | 0.164 | Biliverdin reductase inhibitor | 0.065 0.036 CID_15629705 | ||
| 0.16 | 0.004 | 0.16 | Granulocyte macrophage colony stimulating factor agonist | 0.099 0.037 CID_15629705 | ||
| 0.186 | 0.031 | 0.186 | MAP kinase 3 inhibitor | |||
| 0.192 | 0.038 | 0.192 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.194 | 0.041 | 0.24 | Heat shock protein 90 antagonist | 0.24 0.024 CID_154699726 0.197 0.039 CID_15629705 | CID_154699726 | |
| 0.166 | 0.014 | 0.166 | Electrolyte absorption antagonist | |||
| 0.233 | 0.082 | 0.233 | Calpain inhibitor | |||
| 0.212 | 0.063 | 0.212 | DNA methyltransferase I inhibitor | |||
| 0.162 | 0.013 | 0.162 | Glutamate (mGluR) agonist | |||
| 0.291 | 0.142 | 0.453 | Antibacterial | 0.453 0.056 CID_154699726 0.407 0.074 CID_15629705 | CID_154699726 | |
| 0.151 | 0.004 | 0.151 | Aconitate hydratase inhibitor | 0.07 0.019 CID_15629705 | ||
| 0.189 | 0.042 | 0.189 | Catenin beta inhibitor | |||
| 0.263 | 0.116 | 0.295 | Antithrombotic | 0.241 0.133 CID_154699726 0.295 0.091 CID_15629705 | CID_15629705 | |
| 0.163 | 0.017 | 0.163 | Histidine decarboxylase inhibitor | 0.07 0.051 CID_15629705 | ||
| 0.184 | 0.038 | 0.184 | Cell wall synthesis inhibitor | |||
| 0.171 | 0.028 | 0.171 | Interleukin 1b antagonist | |||
| 0.246 | 0.103 | 0.246 | Lipoxygenase inhibitor | |||
| 0.159 | 0.016 | 0.159 | Phosphofructokinase-1 inhibitor | 0.062 0.054 CID_154699726 0.101 0.031 CID_15629705 | ||
| 0.159 | 0.016 | 0.159 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.079 0.052 CID_154699726 0.101 0.037 CID_15629705 | ||
| 0.18 | 0.038 | 0.18 | Sodium channel (voltage-gated) blocker | |||
| 0.146 | 0.005 | 0.146 | Glutamate (mGluR group II) agonist | |||
| 0.151 | 0.01 | 0.151 | Protein kinase C alpha inhibitor | |||
| 0.156 | 0.015 | 0.156 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.149 | 0.009 | 0.149 | Bromodomain-containing protein 2 inhibitor | |||
| 0.169 | 0.03 | 0.169 | Aminopeptidase B inhibitor | |||
| 0.162 | 0.024 | 0.162 | TRPA1 agonist | |||
| 0.142 | 0.005 | 0.142 | Potassium channel intermediate-conductance Ca-activated blocker | 0.056 0.05 CID_15629705 | ||
| 0.154 | 0.017 | 0.154 | CC chemokine 6 receptor antagonist | |||
| 0.203 | 0.066 | 0.203 | TRKC antagonist | |||
| 0.139 | 0.003 | 0.139 | Acid-sensing ion channel blocker | 0.08 0.005 CID_154699726 0.045 0.021 CID_15629705 | ||
| 0.175 | 0.04 | 0.175 | Cyclooxygenase 2 inhibitor | 0.104 0.1 CID_15629705 | ||
| 0.157 | 0.022 | 0.157 | Topoisomerase II alpha inhibitor | |||
| 0.139 | 0.005 | 0.139 | Glutamate (mGluR2) agonist | |||
| 0.165 | 0.031 | 0.182 | Beta amyloid protein antagonist | 0.121 0.066 CID_154699726 0.182 0.023 CID_15629705 | CID_15629705 | |
| 0.148 | 0.013 | 0.148 | Glutamate decarboxylase inhibitor | 0.069 0.057 CID_15629705 | ||
| 0.149 | 0.015 | 0.149 | Histamine N-methyltransferase inhibitor | |||
| 0.163 | 0.029 | 0.163 | Polo-like kinase-4 inhibitor | |||
| 0.183 | 0.049 | 0.222 | Protein kinase stimulant | 0.222 0.034 CID_154699726 0.182 0.049 CID_15629705 | CID_154699726 | |
| 0.177 | 0.045 | 0.177 | Cytokine production inhibitor | |||
| 0.141 | 0.009 | 0.141 | Glycine receptor antagonist | 0.107 0.027 CID_154699726 0.121 0.017 CID_15629705 | ||
| 0.137 | 0.005 | 0.137 | Topoisomerase II beta inhibitor | 0.049 0.034 CID_15629705 | ||
| 0.145 | 0.014 | 0.145 | Glutamate (mGluR7) agonist | |||
| 0.206 | 0.075 | 0.206 | DNA methylase inhibitor | |||
| 0.153 | 0.021 | 0.153 | Transcription factor STAT6 inhibitor | |||
| 0.157 | 0.026 | 0.157 | Carbonic anhydrase III inhibitor | |||
| 0.155 | 0.024 | 0.155 | Nav1.5 sodium channel blocker | |||
| 0.255 | 0.124 | 0.255 | Prostaglandin dehydrogenase inhibitor | |||
| 0.136 | 0.006 | 0.136 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.055 0.036 CID_15629705 | ||
| 0.167 | 0.037 | 0.167 | Cholesterol synthesis inhibitor | 0.151 0.044 CID_154699726 0.11 0.076 CID_15629705 | ||
| 0.138 | 0.009 | 0.138 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.076 0.022 CID_15629705 | ||
| 0.135 | 0.006 | 0.135 | CD45 antagonist | 0.046 0.045 CID_15629705 | ||
| 0.139 | 0.011 | 0.139 | mTOR complex 2 inhibitor | 0.082 0.064 CID_154699726 0.112 0.022 CID_15629705 | ||
| 0.137 | 0.009 | 0.137 | Glycine receptor agonist | 0.069 0.057 CID_154699726 0.092 0.026 CID_15629705 | ||
| 0.168 | 0.04 | 0.168 | Glutamate receptor antagonist | |||
| 0.229 | 0.101 | 0.229 | Spasmolytic | 0.168 0.147 CID_154699726 | ||
| 0.159 | 0.032 | 0.159 | Falcipain 3 inhibitor | |||
| 0.177 | 0.05 | 0.177 | Thiol protease inhibitor | |||
| 0.155 | 0.029 | 0.155 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.177 | 0.052 | 0.177 | Cyclooxygenase inhibitor | |||
| 0.158 | 0.033 | 0.233 | Microtubule formation inhibitor | 0.233 0.013 CID_154699726 0.197 0.02 CID_15629705 | CID_154699726 | |
| 0.133 | 0.009 | 0.133 | D-Ala-D-Ala ligase inhibitor | 0.085 0.056 CID_15629705 | ||
| 0.128 | 0.004 | 0.128 | Exportin-1 inhibitor | 0.107 0.007 CID_154699726 0.087 0.017 CID_15629705 | ||
| 0.135 | 0.011 | 0.135 | Acyl-CoA dehydrogenase inhibitor | 0.059 0.034 CID_15629705 | ||
| 0.135 | 0.011 | 0.135 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.128 | 0.005 | 0.128 | Phospholipase D inhibitor | 0.089 0.024 CID_15629705 | ||
| 0.151 | 0.028 | 0.151 | AMP-activated protein kinase stimulant | 0.096 0.076 CID_154699726 | ||
| 0.135 | 0.013 | 0.135 | Carbamoyl phosphate synthetase inhibitor | 0.071 0.034 CID_15629705 | ||
| 0.144 | 0.021 | 0.144 | Anabolic | 0.138 0.025 CID_154699726 0.101 0.06 CID_15629705 | ||
| 0.139 | 0.018 | 0.139 | Glutamate dehydrogenase inhibitor | 0.078 0.047 CID_15629705 | ||
| 0.17 | 0.049 | 0.17 | Hemostatic | |||
| 0.159 | 0.037 | 0.159 | Histone deacetylase class III inhibitor | |||
| 0.141 | 0.02 | 0.141 | Glutamate receptor agonist | |||
| 0.168 | 0.047 | 0.168 | Histone deacetylase SIRT1 inhibitor | |||
| 0.202 | 0.081 | 0.202 | Anticonvulsant | |||
| 0.174 | 0.054 | 0.185 | Interferon gamma antagonist | 0.185 0.047 CID_154699726 0.172 0.055 CID_15629705 | CID_154699726 | |
| 0.125 | 0.005 | 0.125 | Glutamate (mGluR6) antagonist | 0.073 0.034 CID_154699726 0.087 0.017 CID_15629705 | ||
| 0.125 | 0.006 | 0.125 | Potassium channel (Ca-activated) blocker | |||
| 0.165 | 0.046 | 0.165 | Toll-Like receptor antagonist | |||
| 0.211 | 0.092 | 0.224 | Antiamyloidogenic | 0.208 0.094 CID_154699726 0.224 0.084 CID_15629705 | CID_15629705 | |
| 0.147 | 0.029 | 0.147 | Potassium channel (Ca-activated) activator | |||
| 0.154 | 0.036 | 0.154 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.136 | 0.019 | 0.136 | GABA A receptor agonist | |||
| 0.159 | 0.042 | 0.159 | Alkylator | 0.133 0.057 CID_154699726 0.118 0.07 CID_15629705 | ||
| 0.151 | 0.034 | 0.151 | Xanthine oxidase inhibitor | |||
| 0.154 | 0.039 | 0.154 | MAP kinase 12 inhibitor | |||
| 0.174 | 0.06 | 0.174 | Cytidine deaminase inhibitor | |||
| 0.119 | 0.005 | 0.119 | Glutamate (mGluR7) antagonist | 0.064 0.054 CID_154699726 0.089 0.018 CID_15629705 | ||
| 0.181 | 0.067 | 0.181 | Tumour necrosis factor antagonist | |||
| 0.163 | 0.05 | 0.163 | Nav1.2 sodium channel blocker | 0.137 0.066 CID_15629705 | ||
| 0.139 | 0.026 | 0.149 | Androgen antagonist | 0.149 0.023 CID_154699726 0.13 0.029 CID_15629705 | CID_154699726 | |
| 0.119 | 0.006 | 0.119 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.079 0.039 CID_15629705 | ||
| 0.156 | 0.043 | 0.156 | Cyclooxygenase 3 inhibitor | |||
| 0.178 | 0.066 | 0.178 | Antipruritic | |||
| 0.138 | 0.026 | 0.138 | Calcium antagonist | |||
| 0.134 | 0.024 | 0.134 | MAP kinase kinase 1 inhibitor | |||
| 0.114 | 0.003 | 0.114 | Alpha 1d adrenoreceptor agonist | 0.047 0.019 CID_154699726 0.051 0.016 CID_15629705 | ||
| 0.124 | 0.014 | 0.124 | GABA aminotransferase inhibitor | |||
| 0.146 | 0.037 | 0.146 | Interleukin 8 antagonist | |||
| 0.171 | 0.062 | 0.171 | Protein-tyrosine phosphatase inhibitor | |||
| 0.113 | 0.005 | 0.113 | Nicotinic alpha3beta2 receptor antagonist | 0.05 0.044 CID_15629705 | ||
| 0.13 | 0.023 | 0.13 | Toll-Like receptor 3 antagonist | |||
| 0.125 | 0.018 | 0.125 | Aminopeptidase I inhibitor | 0.068 0.055 CID_15629705 | ||
| 0.169 | 0.062 | 0.169 | Diuretic | |||
| 0.121 | 0.015 | 0.121 | Argininosuccinate synthase inhibitor | |||
| 0.141 | 0.035 | 0.141 | Check point kinase 2 inhibitor | |||
| 0.158 | 0.053 | 0.158 | Sodium channel blocker | |||
| 0.151 | 0.047 | 0.151 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.151 | 0.047 | 0.151 | Abl kinase inhibitor | |||
| 0.128 | 0.024 | 0.128 | Acetylcholine nicotinic agonist | |||
| 0.136 | 0.033 | 0.136 | Protein kinase C mu inhibitor | |||
| 0.113 | 0.01 | 0.113 | GABA B receptor agonist | |||
| 0.116 | 0.012 | 0.116 | Purinergic P2X1 antagonist | 0.058 0.046 CID_15629705 | ||
| 0.121 | 0.018 | 0.121 | Estrogen receptor alpha antagonist | 0.111 0.022 CID_154699726 0.113 0.021 CID_15629705 | ||
| 0.141 | 0.038 | 0.141 | Mucolytic | |||
| 0.111 | 0.008 | 0.111 | Fatty acid synthase inhibitor | 0.057 0.039 CID_15629705 | ||
| 0.161 | 0.059 | 0.161 | Vascular endothelial growth factor 3 antagonist | |||
| 0.112 | 0.011 | 0.112 | 5 Hydroxytryptamine 3 agonist | |||
| 0.118 | 0.017 | 0.118 | Histone deacetylase SIRT2 inhibitor | |||
| 0.132 | 0.031 | 0.132 | Uric acid excretion stimulant | |||
| 0.167 | 0.067 | 0.167 | Polo-like kinase-3 inhibitor | |||
| 0.104 | 0.004 | 0.104 | Adenylate cyclase 1 inhibitor | 0.051 0.025 CID_15629705 | ||
| 0.113 | 0.013 | 0.113 | Estrogen-related receptor beta agonist | 0.079 0.07 CID_15629705 | ||
| 0.111 | 0.014 | 0.111 | Acetylcholine M5 receptor agonist | |||
| 0.121 | 0.024 | 0.121 | Phosphodiesterase 6D inhibitor | |||
| 0.129 | 0.033 | 0.129 | CDC-like kinase 3 inhibitor | |||
| 0.121 | 0.025 | 0.121 | Macrophage migration inhibitory factor inhibitor | |||
| 0.108 | 0.012 | 0.108 | Vanilloid 4 agonist | |||
| 0.122 | 0.027 | 0.122 | mTOR complex 1 inhibitor | 0.114 0.036 CID_15629705 | ||
| 0.125 | 0.031 | 0.125 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.099 | 0.004 | 0.099 | Dopamine D5 agonist | 0.041 0.026 CID_15629705 | ||
| 0.152 | 0.058 | 0.152 | Alkaline phosphatase inhibitor | |||
| 0.152 | 0.059 | 0.152 | MAO inhibitor | |||
| 0.156 | 0.063 | 0.156 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.137 | 0.045 | 0.137 | MAO A inhibitor | |||
| 0.107 | 0.015 | 0.107 | CC chemokine 5 receptor agonist | |||
| 0.118 | 0.027 | 0.118 | Ornithine decarboxylase inhibitor | |||
| 0.11 | 0.019 | 0.11 | Caspase 7 inhibitor | |||
| 0.097 | 0.007 | 0.097 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.098 | 0.008 | 0.098 | Sphingosine kinase 2 inhibitor | |||
| 0.096 | 0.007 | 0.096 | Calcium channel P-type blocker | 0.062 0.049 CID_15629705 | ||
| 0.114 | 0.025 | 0.114 | Bile acid receptor antagonist | |||
| 0.094 | 0.005 | 0.094 | Retinoid X alpha receptor agonist | 0.032 0.028 CID_15629705 | ||
| 0.135 | 0.047 | 0.135 | Alpha 2b adrenoreceptor antagonist | 0.125 0.054 CID_154699726 | ||
| 0.126 | 0.04 | 0.126 | Beta glucuronidase inhibitor | |||
| 0.093 | 0.007 | 0.093 | DNA helicase inhibitor | |||
| 0.117 | 0.031 | 0.117 | Carbonic anhydrase VI inhibitor | |||
| 0.099 | 0.014 | 0.099 | Protein kinase C beta inhibitor | |||
| 0.102 | 0.017 | 0.102 | Secretase beta inhibitor | |||
| 0.11 | 0.026 | 0.11 | Myeloperoxidase inhibitor | |||
| 0.106 | 0.024 | 0.106 | Interferon agonist | 0.071 0.069 CID_15629705 | ||
| 0.105 | 0.023 | 0.105 | Benzodiazepine agonist | |||
| 0.097 | 0.015 | 0.097 | Aryl hydrocarbon receptor antagonist | |||
| 0.139 | 0.058 | 0.139 | MAP kinase kinase inhibitor | |||
| 0.138 | 0.056 | 0.138 | Nav1.3 sodium channel blocker | 0.111 0.084 CID_15629705 | ||
| 0.088 | 0.007 | 0.088 | Glucose-6-phosphate isomerase inhibitor | 0.046 0.037 CID_154699726 0.06 0.018 CID_15629705 | ||
| 0.094 | 0.012 | 0.094 | Phosphodiesterase 1C inhibitor | |||
| 0.128 | 0.047 | 0.128 | 5-Lipoxygenase inhibitor | |||
| 0.11 | 0.029 | 0.11 | p38 MAP kinase inhibitor | |||
| 0.097 | 0.016 | 0.097 | Androgen agonist | 0.09 0.019 CID_154699726 0.07 0.03 CID_15629705 | ||
| 0.096 | 0.016 | 0.096 | MAP kinase kinase 7 inhibitor | |||
| 0.116 | 0.036 | 0.116 | Protein kinase A inhibitor | |||
| 0.102 | 0.022 | 0.102 | Nav1.7 sodium channel blocker | |||
| 0.148 | 0.068 | 0.148 | Neuropeptide Y1 antagonist | |||
| 0.131 | 0.051 | 0.131 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.112 | 0.033 | 0.112 | Carbonic anhydrase XIII inhibitor | |||
| 0.125 | 0.047 | 0.125 | Expectorant | 0.097 0.073 CID_15629705 | ||
| 0.108 | 0.03 | 0.108 | Glutathione S-transferase inhibitor | |||
| 0.105 | 0.028 | 0.105 | Keratolytic | |||
| 0.102 | 0.025 | 0.102 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.157 | 0.08 | 0.334 | Sigma receptor agonist | 0.334 0.033 CID_154699726 | CID_154699726 | |
| 0.083 | 0.006 | 0.083 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.135 | 0.058 | 0.135 | Vanilloid 1 agonist | |||
| 0.112 | 0.037 | 0.112 | ABCA1 expression enhancer | |||
| 0.086 | 0.01 | 0.086 | 5 Hydroxytryptamine 7 agonist | |||
| 0.086 | 0.01 | 0.086 | Progesterone antagonist | 0.053 0.017 CID_154699726 0.037 0.024 CID_15629705 | ||
| 0.094 | 0.019 | 0.094 | NMDA receptor glycine site agonist | |||
| 0.082 | 0.007 | 0.082 | Retinoid X receptor agonist | |||
| 0.089 | 0.014 | 0.089 | AMPA receptor antagonist | |||
| 0.079 | 0.005 | 0.079 | Geranyltranstransferase inhibitor | 0.039 0.038 CID_15629705 | ||
| 0.083 | 0.009 | 0.083 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.109 | 0.035 | 0.109 | Phosphodiesterase I inhibitor | |||
| 0.093 | 0.019 | 0.093 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.087 | 0.013 | 0.529 | Estrogen receptor beta agonist | 0.13 0.008 CID_154699726 0.529 0.003 CID_15629705 | CID_15629705 | |
| 0.087 | 0.014 | 0.087 | MDM2 inhibitor | |||
| 0.079 | 0.006 | 0.079 | Immunoglobulin Fc receptor antagonist | 0.052 0.051 CID_15629705 | ||
| 0.149 | 0.076 | 0.149 | Acetylcholine M1 receptor antagonist | |||
| 0.091 | 0.018 | 0.091 | Carbonic anhydrase VB inhibitor | |||
| 0.08 | 0.008 | 0.08 | Glutamate (mGluR4) antagonist | |||
| 0.108 | 0.036 | 0.108 | Platelet growth factor antagonist | |||
| 0.142 | 0.07 | 0.142 | Ribosomal protein S6 kinase inhibitor | |||
| 0.098 | 0.026 | 0.098 | Protein kinase B beta inhibitor | |||
| 0.085 | 0.013 | 0.085 | Transcription factor RelA inhibitor | 0.062 0.048 CID_15629705 | ||
| 0.08 | 0.009 | 0.08 | Dihydroorotase inhibitor | |||
| 0.09 | 0.018 | 0.105 | Alpha 2 adrenoreceptor agonist | 0.105 0.013 CID_154699726 | CID_154699726 | |
| 0.101 | 0.03 | 0.101 | Protein kinase B alpha inhibitor | |||
| 0.131 | 0.059 | 0.131 | Anesthetic local | |||
| 0.127 | 0.057 | 0.127 | Monophenol monooxygenase inhibitor | |||
| 0.086 | 0.015 | 0.086 | Nicotinic alpha7 receptor agonist | |||
| 0.1 | 0.031 | 0.1 | Na+ K+ transporting ATPase inhibitor | 0.082 0.048 CID_154699726 0.073 0.057 CID_15629705 | ||
| 0.075 | 0.006 | 0.075 | GABA uptake inhibitor | |||
| 0.12 | 0.051 | 0.12 | MAP kinase kinase kinase inhibitor | |||
| 0.077 | 0.008 | 0.077 | Pregnane X receptor antagonist | |||
| 0.071 | 0.003 | 0.071 | Imidazoline I1 receptor antagonist | 0.02 0.015 CID_154699726 0.037 0.005 CID_15629705 | ||
| 0.088 | 0.02 | 0.088 | NMDA 2C receptor antagonist | |||
| 0.082 | 0.015 | 0.082 | Sphingosine kinase inhibitor | |||
| 0.139 | 0.071 | 0.139 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.082 | 0.014 | 0.082 | 5 Hydroxytryptamine 2 agonist | |||
| 0.078 | 0.011 | 0.078 | Dihydroorotate oxidase inhibitor | |||
| 0.134 | 0.067 | 0.134 | Cyclooxygenase 1 inhibitor | |||
| 0.116 | 0.049 | 0.116 | Urease inhibitor | |||
| 0.118 | 0.051 | 0.131 | Alpha 2c adrenoreceptor antagonist | 0.131 0.042 CID_154699726 0.084 0.083 CID_15629705 | CID_154699726 | |
| 0.079 | 0.013 | 0.079 | Lysine-specific demethylase 1A inhibitor | 0.05 0.044 CID_15629705 | ||
| 0.08 | 0.013 | 0.08 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.088 | 0.022 | 0.088 | CDC25B inhibitor | |||
| 0.077 | 0.011 | 0.077 | Squalene epoxidase inhibitor | 0.047 0.04 CID_15629705 | ||
| 0.099 | 0.033 | 0.099 | Phosphodiesterase 3A inhibitor | |||
| 0.085 | 0.02 | 0.085 | Phosphodiesterase 1B inhibitor | |||
| 0.125 | 0.059 | 0.125 | Protein kinase (CK2) alpha inhibitor | |||
| 0.102 | 0.037 | 0.102 | I kappa B kinase inhibitor | |||
| 0.192 | 0.127 | 0.192 | Cardiotonic | |||
| 0.081 | 0.016 | 0.081 | Phosphodiesterase 1A inhibitor | |||
| 0.145 | 0.08 | 0.145 | Phospholipase A2 inhibitor | |||
| 0.07 | 0.005 | 0.07 | Nerve growth factor antagonist | |||
| 0.1 | 0.035 | 0.1 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.095 | 0.03 | 0.095 | Prostaglandin-E synthase inhibitor | |||
| 0.086 | 0.022 | 0.086 | TRPA1 antagonist | |||
| 0.094 | 0.029 | 0.094 | Carbonic anhydrase V inhibitor | |||
| 0.105 | 0.041 | 0.105 | Pim-3 kinase inhibitor | |||
| 0.087 | 0.023 | 0.087 | Carbonic anhydrase stimulant | |||
| 0.11 | 0.046 | 0.11 | Nitric-oxide synthase inhibitor | |||
| 0.073 | 0.009 | 0.073 | Glutamate (mGluR group III) antagonist | |||
| 0.125 | 0.061 | 0.125 | Proteasome inhibitor | 0.1 0.087 CID_154699726 | ||
| 0.086 | 0.022 | 0.086 | Potassium channel (Tandem pore domain) blocker | |||
| 0.088 | 0.024 | 0.088 | Aromatase inhibitor | 0.082 0.027 CID_154699726 | ||
| 0.077 | 0.014 | 0.077 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.084 | 0.021 | 0.424 | Estrogen agonist | 0.121 0.014 CID_154699726 0.424 0.004 CID_15629705 | CID_15629705 | |
| 0.088 | 0.026 | 0.088 | Beta tubulin antagonist | |||
| 0.086 | 0.023 | 0.086 | Dopamine uptake inhibitor | |||
| 0.115 | 0.053 | 0.115 | MAO B inhibitor | |||
| 0.07 | 0.007 | 0.07 | Benzodiazepine antagonist | |||
| 0.096 | 0.034 | 0.096 | Rho-associated kinase II inhibitor | |||
| 0.07 | 0.008 | 0.07 | Sirtuin 2 inhibitor | |||
| 0.085 | 0.023 | 0.085 | 5 Hydroxytryptamine 2A agonist | |||
| 0.074 | 0.013 | 0.074 | Aldosterone antagonist | |||
| 0.067 | 0.005 | 0.067 | Histamine H1 receptor agonist | |||
| 0.089 | 0.027 | 0.089 | Transforming growth factor antagonist | |||
| 0.189 | 0.127 | 0.189 | Immunostimulant | |||
| 0.097 | 0.036 | 0.097 | Rho-associated kinase inhibitor | |||
| 0.075 | 0.015 | 0.075 | Epithelial sodium channel blocker | |||
| 0.09 | 0.03 | 0.09 | Carbonic anhydrase VA inhibitor | |||
| 0.066 | 0.007 | 0.066 | Guanylate cyclase inhibitor | |||
| 0.081 | 0.021 | 0.081 | I kappa B kinase 2 inhibitor | |||
| 0.069 | 0.009 | 0.069 | Liver X receptor alpha agonist | |||
| 0.071 | 0.012 | 0.071 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.08 | 0.021 | 0.08 | Nicotinic neuronal receptor agonist | |||
| 0.069 | 0.011 | 0.069 | Urate transporter 1 inhibitor | |||
| 0.091 | 0.032 | 0.091 | Check point kinase 1 inhibitor | |||
| 0.075 | 0.018 | 0.075 | Protein kinase C theta inhibitor | |||
| 0.07 | 0.012 | 0.07 | Thymidylate synthase inhibitor | |||
| 0.072 | 0.015 | 0.072 | Ryanodine receptor antagonist | |||
| 0.097 | 0.04 | 0.097 | Inducible nitric-oxide synthase inhibitor | |||
| 0.063 | 0.006 | 0.063 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.066 | 0.009 | 0.066 | Glutamate (mGluR group II) antagonist | |||
| 0.064 | 0.007 | 0.064 | Glutamate (mGluR3) antagonist | |||
| 0.092 | 0.035 | 0.092 | Acetylcholine M4 receptor antagonist | |||
| 0.084 | 0.027 | 0.084 | NMDA receptor agonist | |||
| 0.072 | 0.015 | 0.072 | Alpha-mannosidase inhibitor | 0.053 0.038 CID_15629705 | ||
| 0.091 | 0.035 | 0.091 | Transforming growth factor beta 3 antagonist | |||
| 0.226 | 0.17 | 0.6 | Immunosuppressant | 0.59 0.014 CID_154699726 0.6 0.013 CID_15629705 | CID_15629705 | |
| 0.07 | 0.014 | 0.07 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.066 | 0.01 | 0.066 | Dopamine beta hydroxylase inhibitor | |||
| 0.111 | 0.055 | 0.214 | Nav1.1 sodium channel blocker | 0.129 0.043 CID_154699726 0.214 0.016 CID_15629705 | CID_15629705 | |
| 0.061 | 0.005 | 0.061 | Angiotensin AT1 receptor antagonist | |||
| 0.08 | 0.024 | 0.08 | Interferon inducer | |||
| 0.071 | 0.015 | 0.071 | Potassium channel Kv1.3 blocker | |||
| 0.061 | 0.005 | 0.061 | Melatonin receptor 1A agonist | |||
| 0.066 | 0.011 | 0.066 | Purinergic P2X4 antagonist | |||
| 0.065 | 0.01 | 0.065 | GABA B receptor antagonist | |||
| 0.079 | 0.024 | 0.079 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.079 | 0.025 | 0.079 | Xanthine dehydrogenase inhibitor | |||
| 0.064 | 0.009 | 0.064 | Fumarate hydratase inhibitor | 0.03 0.029 CID_15629705 | ||
| 0.086 | 0.032 | 0.086 | CDC7 inhibitor | |||
| 0.059 | 0.005 | 0.059 | Liver X receptor beta antagonist | |||
| 0.096 | 0.042 | 0.096 | Acetylcholine nicotinic antagonist | 0.083 0.052 CID_154699726 0.083 0.052 CID_15629705 | ||
| 0.069 | 0.015 | 0.069 | Glutamate (mGluR group III) agonist | |||
| 0.072 | 0.019 | 0.072 | Prolactin release inhibitor | |||
| 0.088 | 0.035 | 0.088 | CDC25A inhibitor | |||
| 0.06 | 0.007 | 0.06 | Kainate receptor agonist | 0.041 0.03 CID_15629705 | ||
| 0.073 | 0.02 | 0.073 | Glucosylceramidase inhibitor | 0.05 0.049 CID_15629705 | ||
| 0.067 | 0.014 | 0.067 | Heparanase inhibitor | 0.053 0.036 CID_15629705 | ||
| 0.077 | 0.025 | 0.077 | Protein kinase C eta inhibitor | |||
| 0.09 | 0.037 | 0.09 | NMDA 2 receptor antagonist | |||
| 0.057 | 0.005 | 0.057 | Vanilloid 3 antagonist | 0.036 0.033 CID_154699726 0.037 0.029 CID_15629705 | ||
| 0.063 | 0.011 | 0.063 | Cytokine production stimulant | |||
| 0.074 | 0.022 | 0.074 | Botulinum neurotoxin type A inhibitor | |||
| 0.085 | 0.033 | 0.085 | Neuronal nicotinic receptor antagonist | 0.074 0.042 CID_154699726 0.076 0.04 CID_15629705 | ||
| 0.061 | 0.009 | 0.061 | Diamine oxidase inhibitor | |||
| 0.074 | 0.022 | 0.074 | NMDA 2A receptor antagonist | |||
| 0.102 | 0.05 | 0.102 | Potassium channel (Voltage-sensitive) activator | |||
| 0.079 | 0.028 | 0.079 | Cannabinoid CB1 receptor antagonist | |||
| 0.064 | 0.013 | 0.064 | DNA-dependent protein kinase inhibitor | |||
| 0.204 | 0.153 | 0.204 | Nootropic | |||
| 0.058 | 0.008 | 0.058 | Glutamate (mGluR8) agonist | 0.036 0.031 CID_15629705 | ||
| 0.116 | 0.066 | 0.116 | Caspase 3 inhibitor | |||
| 0.128 | 0.078 | 0.128 | Interleukin 1 antagonist | |||
| 0.058 | 0.007 | 0.058 | Retinoid X receptor antagonist | |||
| 0.074 | 0.024 | 0.074 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.084 | 0.034 | 0.084 | Amidase inhibitor | |||
| 0.054 | 0.005 | 0.054 | Glutamate (mGluR1a) agonist | |||
| 0.074 | 0.024 | 0.074 | Ornithine carbamoyltransferase inhibitor | |||
| 0.131 | 0.082 | 0.131 | Protein kinase (CK1) inhibitor | |||
| 0.098 | 0.048 | 0.098 | Acetylcholine agonist | |||
| 0.057 | 0.008 | 0.057 | Heme oxygenase inhibitor | |||
| 0.074 | 0.025 | 0.074 | Heat shock protein 90 beta antagonist | 0.059 0.042 CID_15629705 | ||
| 0.087 | 0.039 | 0.087 | Cathepsin G inhibitor | |||
| 0.053 | 0.005 | 0.053 | Angiotensin II receptor antagonist | |||
| 0.071 | 0.023 | 0.071 | Protein kinase C epsilon inhibitor | |||
| 0.082 | 0.034 | 0.082 | Sirtuin 1 inhibitor | |||
| 0.054 | 0.006 | 0.054 | NMDA 2D receptor antagonist | |||
| 0.062 | 0.014 | 0.062 | Histamine H2 receptor agonist | |||
| 0.072 | 0.025 | 0.072 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.067 | 0.019 | 0.067 | Potassium channel (Inward rectifier) blocker | |||
| 0.061 | 0.014 | 0.061 | Glutamate (mGluR1a) antagonist | |||
| 0.07 | 0.023 | 0.07 | Toll-Like receptor 8 antagonist | |||
| 0.072 | 0.025 | 0.072 | Cyclin D1 inhibitor | |||
| 0.056 | 0.01 | 0.056 | 5 Hydroxytryptamine 2B agonist | |||
| 0.074 | 0.028 | 0.074 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.087 | 0.04 | 0.087 | Rho-associated kinase I inhibitor | |||
| 0.053 | 0.006 | 0.053 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.054 | 0.008 | 0.054 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.027 0.02 CID_15629705 | ||
| 0.05 | 0.004 | 0.05 | Alpha 2a adrenoreceptor agonist | 0.039 0.004 CID_154699726 0.037 0.004 CID_15629705 | ||
| 0.068 | 0.022 | 0.078 | Nicotinic receptor alpha7 subunit antagonist | 0.078 0.018 CID_154699726 0.071 0.021 CID_15629705 | CID_154699726 | |
| 0.123 | 0.077 | 0.123 | Antibacterial (Helicobacter pylori) | |||
| 0.055 | 0.009 | 0.055 | Liver X receptor beta agonist | |||
| 0.083 | 0.037 | 0.083 | Phosphodiesterase VI inhibitor | |||
| 0.062 | 0.017 | 0.062 | Potassium channel (Inward rectifier) activator | |||
| 0.061 | 0.016 | 0.061 | Mannosidase inhibitor | |||
| 0.105 | 0.06 | 0.105 | Protein kinase (CK2) inhibitor | |||
| 0.068 | 0.023 | 0.068 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.061 | 0.017 | 0.061 | Cholesterol esterase inhibitor | |||
| 0.069 | 0.024 | 0.069 | Cannabinoid CB2 receptor antagonist | |||
| 0.192 | 0.148 | 0.192 | MAP kinase kinase 3 inhibitor | |||
| 0.05 | 0.006 | 0.05 | Retinoid X alpha receptor antagonist | |||
| 0.074 | 0.031 | 0.074 | Adrenaline uptake inhibitor | |||
| 0.059 | 0.017 | 0.059 | Potassium channel (ATP-sensitive) activator | |||
| 0.048 | 0.006 | 0.048 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.05 | 0.008 | 0.05 | Glutamate (mGluR2) antagonist | |||
| 0.078 | 0.037 | 0.078 | Orexin receptor 1 antagonist | |||
| 0.076 | 0.035 | 0.076 | Dopamine D1 antagonist | 0.064 0.045 CID_154699726 | ||
| 0.054 | 0.013 | 0.054 | Sphingosine kinase 1 inhibitor | |||
| 0.069 | 0.029 | 0.069 | Histone deacetylase SIRT3 inhibitor | |||
| 0.047 | 0.006 | 0.047 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.261 | 0.221 | 0.261 | MAP kinase 1 inhibitor | |||
| 0.06 | 0.02 | 0.06 | Oleamide hydrolase inhibitor | |||
| 0.048 | 0.008 | 0.048 | Ceramide glucosyltransferase inhibitor | |||
| 0.051 | 0.011 | 0.051 | MAP3K5 inhibitor | |||
| 0.043 | 0.003 | 0.043 | Imidazoline I2 receptor antagonist | 0.018 0.004 CID_15629705 | ||
| 0.099 | 0.059 | 0.099 | Pim-1 kinase inhibitor | |||
| 0.07 | 0.03 | 0.07 | Glutamate (mGluR1) antagonist | |||
| 0.049 | 0.01 | 0.049 | Liver X receptor antagonist | |||
| 0.093 | 0.053 | 0.093 | Alpha 2 adrenoreceptor antagonist | 0.089 0.056 CID_154699726 | ||
| 0.048 | 0.009 | 0.073 | ATP citrate lysase inhibitor | 0.073 0.004 CID_154699726 0.056 0.006 CID_15629705 | CID_154699726 | |
| 0.077 | 0.038 | 0.077 | MAP kinase kinase 8 inhibitor | |||
| 0.094 | 0.055 | 0.094 | Potassium channel activator | |||
| 0.069 | 0.03 | 0.069 | Potassium channel Kv1.5 blocker | |||
| 0.078 | 0.039 | 0.078 | Alpha adrenoreceptor agonist | 0.078 0.039 CID_154699726 | ||
| 0.045 | 0.007 | 0.045 | Liver X receptor alpha antagonist | |||
| 0.079 | 0.041 | 0.079 | Cannabinoid receptor antagonist | |||
| 0.067 | 0.029 | 0.067 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.112 | 0.074 | 0.112 | Calcium channel N-type blocker | |||
| 0.081 | 0.043 | 0.081 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.061 | 0.023 | 0.061 | Plasminogen activator inhibitor antagonist | |||
| 0.071 | 0.033 | 0.071 | Beta 3 adrenoreceptor antagonist | |||
| 0.051 | 0.013 | 0.051 | Retinoic acid alpha receptor agonist | |||
| 0.116 | 0.078 | 0.168 | c-Src kinase inhibitor | 0.168 0.046 CID_15629705 | CID_15629705 | |
| 0.047 | 0.01 | 0.047 | Free fatty acid receptor 1 antagonist | |||
| 0.048 | 0.011 | 0.048 | Potassium channel small-conductance Ca-activated activator | |||
| 0.057 | 0.02 | 0.057 | NMDA receptor subunit 3B antagonist | |||
| 0.055 | 0.019 | 0.055 | Liver X receptor agonist | |||
| 0.076 | 0.04 | 0.076 | Leukotriene synthesis inhibitor | |||
| 0.072 | 0.036 | 0.072 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.045 | 0.009 | 0.045 | Transforming growth factor beta 2 antagonist | |||
| 0.111 | 0.075 | 0.111 | TRKA antagonist | |||
| 0.064 | 0.028 | 0.064 | Alpha tubulin antagonist | |||
| 0.04 | 0.004 | 0.04 | Complement factor 1s inhibitor | |||
| 0.089 | 0.054 | 0.089 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.04 | 0.005 | 0.04 | Nicotinic acid receptor 2 antagonist | |||
| 0.064 | 0.029 | 0.064 | Bromodomain-containing protein 4 inhibitor | |||
| 0.085 | 0.05 | 0.198 | Thioredoxin reductase inhibitor | 0.198 0.005 CID_154699726 0.153 0.009 CID_15629705 | CID_154699726 | |
| 0.056 | 0.021 | 0.056 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.073 | 0.039 | 0.073 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.044 | 0.01 | 0.044 | Uridine phosphorylase inhibitor | |||
| 0.106 | 0.072 | 0.106 | Protein-tyrosine phosphatase 1B inhibitor | |||
| 0.061 | 0.027 | 0.061 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.059 | 0.025 | 0.059 | Dopamine transporter inhibitor | |||
| 0.051 | 0.017 | 0.051 | Plasmepsin II inhibitor | |||
| 0.102 | 0.068 | 0.102 | Mediator release inhibitor | |||
| 0.049 | 0.015 | 0.049 | AMPA 4 receptor antagonist | |||
| 0.089 | 0.055 | 0.089 | NMDA receptor antagonist | |||
| 0.059 | 0.025 | 0.059 | Prolyl endopeptidase inhibitor | |||
| 0.113 | 0.079 | 0.113 | Protein kinase (CK1) delta inhibitor | |||
| 0.038 | 0.005 | 0.038 | Hedgehog signaling activator | |||
| 0.054 | 0.021 | 0.054 | Benzodiazepine inverse agonist | |||
| 0.04 | 0.007 | 0.04 | Purinergic P2Y15 antagonist | 0.027 0.024 CID_15629705 | ||
| 0.047 | 0.014 | 0.047 | Integrin alpha2 antagonist | |||
| 0.081 | 0.048 | 0.081 | Alpha 2a adrenoreceptor antagonist | 0.071 0.057 CID_154699726 | ||
| 0.043 | 0.011 | 0.043 | Cholesterol ester transfer protein antagonist | |||
| 0.059 | 0.027 | 0.059 | Transforming growth factor beta 1 antagonist | |||
| 0.041 | 0.009 | 0.041 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.056 | 0.024 | 0.056 | HCV NS3/NS4A protease inhibitor | 0.048 0.035 CID_154699726 | ||
| 0.05 | 0.019 | 0.05 | Thymidine kinase inhibitor | |||
| 0.048 | 0.016 | 0.048 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.046 | 0.014 | 0.046 | Delayed rectifier potassium channel blocker | |||
| 0.052 | 0.02 | 0.052 | AICAR transformylase inhibitor | |||
| 0.047 | 0.015 | 0.047 | Potassium channel Kv1.1 blocker | |||
| 0.055 | 0.024 | 0.055 | 5 Hydroxytryptamine 2C agonist | |||
| 0.045 | 0.013 | 0.045 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.06 | 0.029 | 0.06 | Leukotriene C antagonist | |||
| 0.064 | 0.033 | 0.064 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.048 | 0.018 | 0.118 | Estrogen receptor alpha agonist | 0.061 0.015 CID_154699726 0.118 0.007 CID_15629705 | CID_15629705 | |
| 0.037 | 0.006 | 0.037 | Lysophosphatidic acid receptor 1 agonist | 0.023 0.021 CID_15629705 | ||
| 0.048 | 0.017 | 0.048 | Vascular adhesion protein 1 inhibitor | |||
| 0.053 | 0.023 | 0.053 | Glutamate (mGluR5) agonist | |||
| 0.048 | 0.017 | 0.048 | TRPM8 blocker | |||
| 0.034 | 0.004 | 0.034 | Alpha 2c adrenoreceptor agonist | 0.033 0.004 CID_154699726 0.027 0.005 CID_15629705 | ||
| 0.046 | 0.016 | 0.046 | Phosphoglycerate kinase inhibitor | |||
| 0.045 | 0.015 | 0.045 | CF transmembrane conductance regulator antagonist | |||
| 0.048 | 0.018 | 0.048 | Histone deacetylase 9 inhibitor | |||
| 0.051 | 0.021 | 0.051 | Kainate receptor antagonist | |||
| 0.037 | 0.007 | 0.037 | HCV NS5A inhibitor | |||
| 0.053 | 0.024 | 0.053 | Purinergic P2Y antagonist | |||
| 0.109 | 0.08 | 0.109 | Acetylcholine muscarinic antagonist | |||
| 0.057 | 0.028 | 0.057 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.049 | 0.02 | 0.049 | NMDA receptor subunit 3A antagonist | |||
| 0.052 | 0.023 | 0.052 | Sphingosine 1-phosphate receptor agonist | |||
| 0.042 | 0.013 | 0.042 | 5 Hydroxytryptamine 1D agonist | |||
| 0.084 | 0.056 | 0.084 | Histamine H2 receptor antagonist | |||
| 0.088 | 0.06 | 0.164 | ATPase (Vacuolar H+) inhibitor | 0.164 0.005 CID_154699726 0.158 0.006 CID_15629705 | CID_154699726 | |
| 0.047 | 0.019 | 0.047 | Dihydropteroate synthase inhibitor | |||
| 0.036 | 0.008 | 0.036 | Estrogen-related receptor gamma antagonist | |||
| 0.037 | 0.01 | 0.037 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.033 | 0.006 | 0.033 | Acid ceramidase inhibitor | |||
| 0.054 | 0.026 | 0.054 | Adenosine deaminase inhibitor | |||
| 0.064 | 0.037 | 0.064 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.095 | 0.068 | 0.095 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.054 | 0.027 | 0.054 | Glutamate (mGluR group I) agonist | |||
| 0.046 | 0.02 | 0.046 | Histone deacetylase 7 inhibitor | |||
| 0.063 | 0.036 | 0.063 | Carbonic anhydrase IX inhibitor | |||
| 0.099 | 0.072 | 0.099 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.036 | 0.01 | 0.036 | 5 Hydroxytryptamine 6 agonist | |||
| 0.053 | 0.027 | 0.053 | Histamine H4 receptor antagonist | |||
| 0.032 | 0.006 | 0.032 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.051 | 0.025 | 0.051 | CC chemokine 4 receptor antagonist | |||
| 0.033 | 0.007 | 0.033 | Vanilloid 2 agonist | |||
| 0.044 | 0.018 | 0.044 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.034 | 0.008 | 0.034 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.045 | 0.019 | 0.045 | Kainate receptor 2 antagonist | |||
| 0.04 | 0.015 | 0.04 | Calcium release-activated channel blocker | |||
| 0.069 | 0.043 | 0.069 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.034 | 0.009 | 0.034 | Integrin alpha2beta1 antagonist | |||
| 0.04 | 0.015 | 0.04 | Melatonin 1 agonist | |||
| 0.048 | 0.022 | 0.048 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.039 | 0.014 | 0.039 | Protein kinase (CK2) beta inhibitor | |||
| 0.039 | 0.014 | 0.039 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.092 | 0.067 | 0.092 | Platelet activating factor alpha antagonist | |||
| 0.043 | 0.018 | 0.043 | Nicotinic acid receptor agonist | |||
| 0.057 | 0.032 | 0.057 | Leukotriene B4 antagonist | |||
| 0.037 | 0.012 | 0.037 | Angiotensin AT2 receptor antagonist | |||
| 0.04 | 0.016 | 0.04 | Glutamate (mGluR4) agonist | |||
| 0.034 | 0.009 | 0.034 | Myristoyl transferase inhibitor | |||
| 0.078 | 0.053 | 0.078 | MAP kinase 10 inhibitor | |||
| 0.073 | 0.048 | 0.073 | Calcium channel L-type blocker | |||
| 0.043 | 0.019 | 0.043 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.072 | 0.048 | 0.072 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.03 | 0.005 | 0.03 | Retinoic acid receptor antagonist | |||
| 0.03 | 0.006 | 0.03 | Retinoic acid alpha receptor antagonist | |||
| 0.029 | 0.005 | 0.029 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.028 | 0.005 | 0.028 | Retinoid X beta receptor antagonist | |||
| 0.081 | 0.057 | 0.081 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.047 | 0.023 | 0.047 | Dihydrofolate reductase inhibitor | |||
| 0.083 | 0.059 | 0.083 | Phosphodiesterase IV inhibitor | |||
| 0.155 | 0.132 | 0.155 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.068 | 0.045 | 0.068 | Potassium channel (ATP-sensitive) blocker | |||
| 0.032 | 0.01 | 0.032 | Thymidine phosphorylase inhibitor | |||
| 0.04 | 0.017 | 0.04 | ATM kinase inhibitor | |||
| 0.034 | 0.012 | 0.034 | MAP3K8 inhibitor | |||
| 0.058 | 0.035 | 0.058 | MAP kinase kinase 9 inhibitor | |||
| 0.063 | 0.04 | 0.063 | Transcription factor AP-1 inhibitor | |||
| 0.037 | 0.014 | 0.037 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.031 | 0.009 | 0.031 | Adenosine kinase inhibitor | |||
| 0.025 | 0.003 | 0.025 | Progesterone receptor A antagonist | 0.019 0.004 CID_154699726 0.019 0.004 CID_15629705 | ||
| 0.047 | 0.026 | 0.047 | Oxytocin agonist | |||
| 0.031 | 0.009 | 0.031 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.031 | 0.009 | 0.031 | Geranylgeranyltransferase inhibitor | |||
| 0.046 | 0.024 | 0.046 | CDK5/p25 inhibitor | |||
| 0.108 | 0.086 | 0.109 | Cholinergic antagonist | 0.109 0.084 CID_154699726 | CID_154699726 | |
| 0.03 | 0.008 | 0.03 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.043 | 0.022 | 0.043 | Membrane dipeptidase inhibitor | |||
| 0.032 | 0.011 | 0.032 | Calcium-sensing receptor agonist | |||
| 0.027 | 0.006 | 0.027 | Progesterone receptor B antagonist | 0.018 0.015 CID_154699726 | ||
| 0.025 | 0.005 | 0.025 | Antibiotic Anthracycline-like | 0.018 0.016 CID_15629705 | ||
| 0.028 | 0.008 | 0.028 | Angiotensin AT1A receptor antagonist | |||
| 0.035 | 0.016 | 0.035 | Glutamate (mGluR3) agonist | |||
| 0.03 | 0.01 | 0.03 | Glutamate (mGluR1) agonist | |||
| 0.032 | 0.012 | 0.04 | Sodium/glucose cotransporter 2 inhibitor | 0.04 0.009 CID_154699726 0.03 0.013 CID_15629705 | CID_154699726 | |
| 0.03 | 0.011 | 0.03 | Complement factor 1r inhibitor | |||
| 0.031 | 0.011 | 0.031 | Glucosylceramidase stimulant | |||
| 0.025 | 0.005 | 0.025 | Nicotinic acid receptor 1 antagonist | |||
| 0.048 | 0.029 | 0.048 | Farnesyltransferase inhibitor | |||
| 0.054 | 0.035 | 0.054 | Carbonic anhydrase XII inhibitor | |||
| 0.108 | 0.089 | 0.108 | RET inhibitor | |||
| 0.105 | 0.086 | 0.105 | Acetylcholine antagonist | 0.104 0.087 CID_154699726 | ||
| 0.093 | 0.074 | 0.093 | Gastric antisecretory | |||
| 0.023 | 0.005 | 0.023 | Complement factor D inhibitor | |||
| 0.033 | 0.015 | 0.033 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.037 | 0.019 | 0.037 | Melatonin 2 agonist | |||
| 0.023 | 0.006 | 0.023 | Microsomal triglyceride transfer protein inhibitor | |||
| 0.022 | 0.005 | 0.022 | Thromboxane A2 agonist | |||
| 0.06 | 0.042 | 0.06 | Acetylcholine M5 receptor antagonist | |||
| 0.078 | 0.06 | 0.078 | Adrenaline agonist | |||
| 0.09 | 0.073 | 0.09 | MAP kinase 8 inhibitor | |||
| 0.055 | 0.037 | 0.055 | GABA receptor antagonist | |||
| 0.026 | 0.008 | 0.135 | Progesterone agonist | 0.023 0.009 CID_154699726 0.135 0.003 CID_15629705 | CID_15629705 | |
| 0.025 | 0.008 | 0.025 | Retinoic acid beta receptor agonist | |||
| 0.072 | 0.055 | 0.072 | Adenosine A3 receptor antagonist | |||
| 0.036 | 0.018 | 0.036 | Dipeptidyl peptidase II inhibitor | |||
| 0.04 | 0.023 | 0.04 | Farnesoid X receptor agonist | |||
| 0.054 | 0.037 | 0.054 | GABA A receptor antagonist | |||
| 0.04 | 0.023 | 0.04 | 5-Alpha-reductase inhibitor | |||
| 0.065 | 0.048 | 0.065 | Orexin receptor antagonist | |||
| 0.031 | 0.014 | 0.031 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.023 | 0.007 | 0.023 | Alpha 2b adrenoreceptor agonist | |||
| 0.095 | 0.078 | 0.095 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.059 | 0.042 | 0.059 | Protein kinase C iota inhibitor | |||
| 0.021 | 0.004 | 0.021 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.054 | 0.038 | 0.054 | Pim-2 kinase inhibitor | |||
| 0.061 | 0.045 | 0.061 | Beta 2 adrenoreceptor agonist | |||
| 0.04 | 0.024 | 0.04 | DNA gyrase subunit B inhibitor | |||
| 0.041 | 0.024 | 0.041 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.049 | 0.033 | 0.117 | Mineralocorticoid receptor antagonist | 0.045 0.038 CID_154699726 0.117 0.006 CID_15629705 | CID_15629705 | |
| 0.026 | 0.01 | 0.026 | Isoleucine-tRNA ligase inhibitor | |||
| 0.033 | 0.018 | 0.033 | Epoxide hydrolase 1 inhibitor | |||
| 0.055 | 0.039 | 0.055 | Bombesin 3 receptor antagonist | |||
| 0.022 | 0.006 | 0.022 | NMDA receptor phencyclidine site antagonist | 0.014 0.012 CID_154699726 | ||
| 0.033 | 0.018 | 0.033 | Dipeptidyl peptidase I inhibitor | |||
| 0.08 | 0.065 | 0.08 | Bcr-Abl kinase inhibitor | |||
| 0.056 | 0.041 | 0.056 | Alpha 1 adrenoreceptor agonist | |||
| 0.059 | 0.044 | 0.059 | Cannabinoid CB1 receptor agonist | |||
| 0.022 | 0.007 | 0.022 | Carbonic anhydrase VIII inhibitor | |||
| 0.022 | 0.007 | 0.022 | Carbonic anhydrase X inhibitor | |||
| 0.044 | 0.029 | 0.044 | Carbonic anhydrase IV inhibitor | |||
| 0.028 | 0.013 | 0.035 | Sodium/glucose cotransporter inhibitor | 0.035 0.008 CID_154699726 0.026 0.016 CID_15629705 | CID_154699726 | |
| 0.11 | 0.096 | 0.11 | Tyrosine-protein kinase receptor antagonist | |||
| 0.034 | 0.019 | 0.034 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.019 | 0.005 | 0.019 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.053 | 0.04 | 0.053 | Thromboxane synthase inhibitor | |||
| 0.055 | 0.042 | 0.055 | Kallikrein 1 inhibitor | |||
| 0.034 | 0.021 | 0.034 | Melatonin agonist | |||
| 0.085 | 0.072 | 0.085 | Polo-like kinase-1 inhibitor | |||
| 0.062 | 0.05 | 0.062 | Histone deacetylase inhibitor | |||
| 0.037 | 0.025 | 0.037 | Arginase inhibitor | |||
| 0.02 | 0.008 | 0.02 | Telomerase stimulant | |||
| 0.041 | 0.029 | 0.041 | Histone deacetylase 8 inhibitor | |||
| 0.059 | 0.047 | 0.059 | Carbonic anhydrase inhibitor | |||
| 0.039 | 0.027 | 0.039 | Leukotriene C4 antagonist | |||
| 0.048 | 0.036 | 0.048 | Carbonic anhydrase XIV inhibitor | |||
| 0.018 | 0.007 | 0.018 | Angiotensin AT1B receptor antagonist | |||
| 0.062 | 0.051 | 0.062 | Beta adrenoreceptor antagonist | |||
| 0.032 | 0.02 | 0.032 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.026 | 0.014 | 0.026 | Prostaglandin EP2 agonist | |||
| 0.022 | 0.011 | 0.022 | Toll-Like receptor 8 agonist | |||
| 0.035 | 0.023 | 0.035 | RNA-directed RNA polymerase inhibitor | |||
| 0.02 | 0.009 | 0.02 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.043 | 0.032 | 0.043 | Phosphodiesterase 3B inhibitor | |||
| 0.071 | 0.06 | 0.071 | Glutamate (mGluR) antagonist | |||
| 0.045 | 0.035 | 0.045 | Urokinase inhibitor | |||
| 0.069 | 0.058 | 0.069 | Metalloproteinase-9 inhibitor | |||
| 0.024 | 0.014 | 0.024 | Retinoic acid receptor agonist | |||
| 0.018 | 0.008 | 0.018 | CDK2/cyclin A3 inhibitor | |||
| 0.12 | 0.11 | 0.12 | Insulin secretagoues | |||
| 0.051 | 0.041 | 0.051 | Dipeptidyl peptidase inhibitor | |||
| 0.08 | 0.07 | 0.08 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.033 | 0.023 | 0.033 | ATR kinase inhibitor | |||
| 0.015 | 0.005 | 0.015 | Retinoic acid beta receptor antagonist | |||
| 0.019 | 0.01 | 0.019 | CXC chemokine 5 receptor antagonist | |||
| 0.051 | 0.041 | 0.051 | 5 Hydroxytryptamine 1B agonist | |||
| 0.024 | 0.014 | 0.024 | Prostaglandin F2 alpha agonist | |||
| 0.019 | 0.01 | 0.019 | G-protein-coupled receptor 120 agonist | |||
| 0.052 | 0.043 | 0.052 | Phosphodiesterase 4C inhibitor | |||
| 0.034 | 0.025 | 0.034 | Adenosine uptake inhibitor | |||
| 0.044 | 0.035 | 0.044 | Glycine transporter 2 inhibitor | |||
| 0.05 | 0.041 | 0.05 | Histamine agonist | |||
| 0.047 | 0.039 | 0.047 | Dopamine D4 agonist | |||
| 0.052 | 0.044 | 0.052 | Beta 1 adrenoreceptor antagonist | |||
| 0.053 | 0.045 | 0.053 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.048 | 0.04 | 0.048 | mTOR inhibitor | |||
| 0.028 | 0.02 | 0.028 | Thrombin receptor antagonist | |||
| 0.019 | 0.011 | 0.019 | Cyclin T1 inhibitor | |||
| 0.025 | 0.018 | 0.025 | Prostaglandin H2 antagonist | |||
| 0.033 | 0.025 | 0.033 | Purinergic P2Y2 antagonist | |||
| 0.027 | 0.02 | 0.027 | LFA antagonist | |||
| 0.021 | 0.014 | 0.021 | Neuraminidase (Influenza B) inhibitor | |||
| 0.021 | 0.014 | 0.021 | Factor XIII inhibitor | |||
| 0.011 | 0.003 | 0.011 | DNA topoisomerase III inhibitor | |||
| 0.035 | 0.028 | 0.035 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.055 | 0.048 | 0.055 | Acetylcholine M3 receptor antagonist | |||
| 0.047 | 0.04 | 0.047 | Beta 2 adrenoreceptor antagonist | |||
| 0.014 | 0.007 | 0.014 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.046 | 0.04 | 0.046 | Bombesin 2 receptor antagonist | |||
| 0.021 | 0.015 | 0.021 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.021 | 0.015 | 0.021 | Kainate receptor 1 antagonist | |||
| 0.026 | 0.02 | 0.026 | Lysine carboxypeptidase inhibitor | |||
| 0.014 | 0.008 | 0.014 | Carbonic anhydrase XI inhibitor | |||
| 0.013 | 0.007 | 0.013 | Retinoic acid receptor gamma antagonist | |||
| 0.019 | 0.014 | 0.019 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.027 | 0.021 | 0.027 | Cyclin E2 inhibitor | |||
| 0.016 | 0.01 | 0.016 | Purinergic P2Y1 agonist | |||
| 0.041 | 0.036 | 0.041 | Phosphorylase inhibitor | |||
| 0.087 | 0.082 | 0.087 | Insulin receptor antagonist | |||
| 0.052 | 0.046 | 0.052 | Plasminogen activator inhibitor | |||
| 0.013 | 0.008 | 0.013 | Egl nine homolog 3 inhibitor | |||
| 0.055 | 0.05 | 0.055 | Dopamine D3 antagonist | |||
| 0.008 | 0.003 | 0.008 | CC chemokine 6 receptor agonist | |||
| 0.058 | 0.053 | 0.058 | Leukotriene antagonist | |||
| 0.022 | 0.017 | 0.022 | ICAM 1 antagonist | |||
| 0.012 | 0.008 | 0.012 | Melatonin 2 antagonist | |||
| 0.013 | 0.009 | 0.013 | Cyclin D2 inhibitor | |||
| 0.011 | 0.006 | 0.011 | Angiotensin AT2 receptor agonist | |||
| 0.019 | 0.014 | 0.019 | Apolipoprotein B inhibitor | |||
| 0.012 | 0.008 | 0.012 | Glutamate (mGluR6) agonist | |||
| 0.116 | 0.113 | 0.116 | Farnesoid X receptor antagonist | |||
| 0.028 | 0.024 | 0.028 | Peptide deformylase inhibitor | |||
| 0.016 | 0.012 | 0.016 | Nicotinic alpha4 receptor agonist | |||
| 0.032 | 0.028 | 0.032 | Protein kinase C beta I inhibitor | |||
| 0.027 | 0.023 | 0.027 | Glucagon receptor antagonist | |||
| 0.145 | 0.141 | 0.145 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.062 | 0.059 | 0.062 | Elastase 1 inhibitor | |||
| 0.029 | 0.025 | 0.029 | Cyclophilin A inhibitor | |||
| 0.047 | 0.044 | 0.047 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.018 | 0.015 | 0.018 | Estrogen-related receptor gamma agonist | |||
| 0.034 | 0.031 | 0.034 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.007 | 0.004 | 0.007 | Integrin alpha5beta6 antagonist | |||
| 0.028 | 0.026 | 0.028 | HCV NS5B polymerase inhibitor | |||
| 0.051 | 0.049 | 0.051 | Cathepsin L inhibitor | |||
| 0.013 | 0.011 | 0.013 | Melatonin receptor 1A antagonist | |||
| 0.069 | 0.067 | 0.069 | Fibroblast growth factor 3 antagonist | |||
| 0.069 | 0.067 | 0.069 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.048 | 0.046 | 0.048 | Carbonic anhydrase II inhibitor | |||
| 0.054 | 0.052 | 0.054 | Cyclin A1 inhibitor | |||
| 0.057 | 0.055 | 0.057 | Neutrophil collagenase inhibitor | |||
| 0.047 | 0.046 | 0.047 | Carbonic anhydrase I inhibitor | |||
| 0.115 | 0.113 | 0.115 | Src kinase inhibitor | |||
| 0.128 | 0.127 | 0.128 | Amyloid beta aggregation inhibitor | |||
| 0.01 | 0.009 | 0.01 | Thromboxane agonist | |||
| 0.026 | 0.025 | 0.026 | CDK4/cyclin D3 inhibitor | |||
| 0.029 | 0.028 | 0.029 | Calcitonin receptor agonist | |||
| 0.041 | 0.04 | 0.041 | Glycine transporter inhibitor | |||
| 0.019 | 0.018 | 0.019 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.059 | 0.058 | 0.059 | Phosphodiesterase 4B inhibitor | |||
| 0.088 | 0.087 | 0.088 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.019 | 0.018 | 0.019 | Retinoid X beta receptor agonist | |||
| 0.014 | 0.013 | 0.014 | CXC chemokine 4 receptor agonist | |||
| 0.026 | 0.026 | 0.096 | Glucocorticoid antagonist | 0.09 0.005 CID_154699726 0.096 0.005 CID_15629705 | CID_15629705 | |
| 0.096 | 0.108 | 0.173 | Interleukin 2 antagonist | 0.173 0.011 CID_154699726 0.113 0.057 CID_15629705 | CID_154699726 | |
| 0.153 | 0.174 | 0.393 | ErbB-1 antagonist | 0.216 0.073 CID_154699726 0.393 0.017 CID_15629705 | CID_15629705 | |
| 0.026 | 0.051 | 0.102 | Dopamine D5 antagonist | 0.102 0.009 CID_154699726 | CID_154699726 | |
| 0.145 | 0.172 | 0.267 | Antioxidant | 0.267 0.075 CID_154699726 0.188 0.124 CID_15629705 | CID_154699726 | |
| 0.117 | 0.167 | 0.682 | Antimitotic | 0.682 0.005 CID_154699726 0.553 0.009 CID_15629705 | CID_154699726 | |
| 0.04 | 0.094 | 0.058 | HIV-1 integrase (3'-Processing) inhibitor | 0.058 0.049 CID_154699726 | CID_154699726 | |
| 0.104 | 0.169 | 0.332 | Nitric oxide antagonist | 0.332 0.035 CID_154699726 0.324 0.036 CID_15629705 | CID_154699726 | |
| 0.093 | 0.22 | 0.353 | Interleukin 6 antagonist | 0.353 0.01 CID_154699726 0.223 0.03 CID_15629705 | CID_154699726 | |
| 0.097 | 0.244 | 0.281 | Lipocortins synthesis antagonist | 0.281 0.025 CID_154699726 | CID_154699726 | |
| 0.027 | 0.208 | 0.21 | MAP3K7 inhibitor | 0.21 0.005 CID_154699726 0.189 0.007 CID_15629705 | CID_154699726 | |
| 0.016 | 0.205 | 0.338 | Antineoplastic antibiotic | 0.338 0.008 CID_154699726 0.26 0.013 CID_15629705 | CID_154699726 | |
| 0.039 | 0.262 | 0.172 | M17 leucyl aminopeptidase inhibitor | 0.172 0.043 CID_154699726 | CID_154699726 | |
| 0.069 | 0.485 | 0.248 | Immunomodulator | 0.248 0.116 CID_154699726 0.198 0.167 CID_15629705 | CID_154699726 | |
| 0.042 | 0.462 | 0.34 | Thioredoxin glutathione reductase inhibitor | 0.34 0.081 CID_154699726 | CID_154699726 | |
| 0.005 | 0.533 | 0.062 | Microtubule stabilization | 0.061 0.013 CID_154699726 0.062 0.012 CID_15629705 | CID_15629705 | |
| 0.016 | 0.55 | 0.149 | Acetylcholine M3 receptor agonist | 0.149 0.02 CID_154699726 | CID_154699726 | |
| 0.001 | 0.692 | 0.02 | Antibiotic Macrolide-like | 0.02 0.007 CID_154699726 0.017 0.008 CID_15629705 | CID_154699726 | |
| 0.007 | 0.814 | 0.039 | Antibiotic Aminoglycoside-like | 0.039 0.022 CID_15629705 | CID_15629705 | |
| 0.005 | 0.858 | 0.087 | Protein 50S ribosomal subunit inhibitor | 0.087 0.017 CID_154699726 0.081 0.019 CID_15629705 | CID_154699726 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |